Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Licenses DNA-Based Weight Management Algorithm from GeneOb

NEW YORK, June 21 (GenomeWeb News) - Interleukin Genetics has licensed an algorithm from GeneOb to develop a genetic weight management test, Interleukin said today.


GeneOb's technology uses specific genetic markers to determine risk of individual weight gain and response to weight-loss programs.


Interleukin Genetics intends to release its genetic weight management test next year through its commercialization partner, Alticor.


Under the licensing agreement, Interleukin Genetics has the exclusive right to market the genetic test based on GeneOb's algorithm in North America through multi-level marketing channels.


The companies also agreed to negotiate a pre-determined period license for additional products, undisclosed at this time, that use GeneOb's technology and Interleukin Genetics' expertise.


Financial terms of the agreement were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.